Clinical Trial Update: The Effects of Intensive Insulin on Somatic and Visceral Protein Turnover in Acute Kidney Injury (AKI) [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating intensive insulin effects on somatic and visceral protein turnover in acute kidney injury has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Vanderbilt University | Conditions: Acute Renal Failure | Phase 2 | Status: WITHDRAWN